Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Jan 7, 2021 (6 years ago)

Mephyton (phytonadione)

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Impurities/Degradation Specifications:Out of specification during the 24 month stability testing of Impurity D.

Cause type: Impurity / degradation

An impurity or degradation product above its limit - other than nitrosamines. Unexpected substances in a batch can make it unsafe or less effective, even when the active ingredient is present. All impurity / degradation recalls.

What was recalled

Mephyton (phytonadione) Tablets 5mg, 100-count bottle, Rx Only, Manufactured for: Valeant Pharmaceuticals North America, LLC Bridgewater, NJ 08807 USA NDC 0187-1704-05

Affected NDC 0187-1704-05

Compare with the code on your package — it is the most precise check available.

Drug: Phytonadione

Recalling firm
Bausch Health Companies, Inc.
NDC code
0187-1704-05
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0243-2021 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Phytonadione recalls

See all
Class III · Low risk

Phytonadione Tablets 5 mg

Failed Impurities Specification: Out of specification when measuring the impurity degradant D level.

Terminated Impurity / degradation AVKARE Inc. NDC 50268-661-13 D-0631-2021

Other recalls by Bausch Health Companies, Inc.

All 2021 recalls
Class III · Low risk

Phytonadione Tablets 5mg

Failed Impurities/Degradation Specifications:Out of specification during the 24 month stability testing of Impurity D.

Terminated Impurity / degradation Bausch Health Companies, Inc. NDC 68682-170-30 D-0244-2021